Astrana Health, Inc. (ASTH)

Market Cap	1.36B -24.1%
Revenue (ttm)	3.18B +56.4%
Net Income	22.49M -47.9%
EPS	0.46 -49.1%
Shares Out	49.47M
PE Ratio	61.61
Forward PE	22.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	118,118
Open	28.33
Previous Close	28.23
Day's Range	27.48 - 28.43
52-Week Range	18.08 - 34.80
Beta	0.77
Analysts	Strong Buy
Price Target	34.00 (+23.55%)
Earnings Date	May 7, 2026

About ASTH

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients prima...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ASTH
• Website: https://www.astranahealth.com

Financial Performance

In 2025, Astrana Health's revenue was $3.18 billion, an increase of 56.39% compared to the previous year's $2.03 billion. Earnings were $22.49 million, a decrease of -47.89%.

Analyst Summary

According to 6 analysts, the average rating for ASTH stock is "Strong Buy." The 12-month stock price target is $34.0, which is an increase of 23.55% from the latest price.

Price Target

$34.0

(23.55% upside)

Analyst Consensus: Strong Buy